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ABSTRACT 
Almost 40% of the new chemical entities at present self find out poorly water soluble drugs. Badly water soluble drugs have solubility and 
dissolution related bioavailability problems. Solubility is one of the most important parameter to give desired concentration of drug in systemic 
circulation to get its pharmacological response. Orally administered drugs obtained completely absorb only when they show fair solubility in 
gastric medium and such drugs shows good bioavailability. The solubility and dissolution properties of drugs perform an valuable role in the 
process of formulation development. Enhancement of solubility of drug is the most challenging job in drug development process. Solubilization 
may be affected by co solvent water interaction, micellar solubilization, reduction in particle size, inclusion complexes, solid dispersion, and 
change in polymorph. This review highlight various techniques of solubility enhancement with special emphasis on Chemical modification 
methods like Salt formation, Co-crystallization, Co-solvency, Hydrotropy, use of novel solubilizer etc along with physical modification techniques. 
Keywords: Salt formation, Co-crystallization, Solubility, particle technologies, Milling solubility enhancement, Cosolvent, physical and chemical 
methods. 
 
Article Info: Received 08 Feb 2019;     Review Completed 09 March 2019;     Accepted 12 March 2019;     Available online 15 March 2019 
Cite this article as: 
Patel MSN, Ahmed MH, Saqib M, Shaikh SN, Chemical Modification: A unique solutions to Solubility problem, Journal of 
Drug Delivery and Therapeutics. 2019; 9(2):542-546     http://dx.doi.org/10.22270/jddt.v9i2.2432                                                    
*Address for Correspondence:  






Solubility is defined in quantitative terms as the 
concentration of solute in saturated solution at a certain 
temperature, qualitatively; it is defined as the spontaneous 
interaction of two or more substances to form a homogenous 
molecular dispersion. Solubilization of poorly soluble drugs 
is a frequently encountered challenge in screening studies of 
new chemical entities as well as in formulation design and 
development1.  
Drug Solubility and Bioavailability Expressions 
The Indian Pharmacopoeia lists the solubility of drugs as the 
number of milliliters of solvent in which 1 gm of solute will 
dissolve. Solubility can also be expressed as molality, Mole 
fraction and percent by weight and percent weight in 
volume. Increase in solubility their increase in bioavailability 
of drug.2,3 
 
Table 1 Descriptive Terms of Solubility4,5 
Descriptive Terms 
Parts of Solvent Required 
for 1 Part of Solute 
Very Soluble Less than 1 
Freely Soluble 1 to 10 
Soluble 10 to 30 
Sparingly Soluble 30 to 100 
Slightly Soluble 100 to 1000 
Very Slightly Soluble 1000 to 10000 
Practically Insoluble or 
Insoluble 
More Than 10000 
 
Factors affecting solubility. 
1. Particle Size 
2. Temperature 
3. Pressure 
4. Nature of the solute and solvent 
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 BCS classification of drugs 9 
Bcs class solubility permeability absorption pattern 
            1 low low poorly absorb 
            2 low  high well absorb 
            3 high  high well absorb 
            4 high low variable 
 
Importance of solubility   determination:- 
Drug absorption requires that molecules be in solution at the 
absorption site. Dissolution of solid dosage forms in gastro 
intestinal fluids is a prerequisite to the delivery of a drug to 
the systemic circulation following oral administration5. The 
improvement in oral bioavailability be able to attain by 
decrease the hepatic first pass metabolism. That’s related 
difficulties by means of conventional dosage form are able to 
reduce by some appropriate novel drug delivery systems like 
use of self-emulsifying microemulsion drug delivery system, 
lipids nanoparticles and microemulsion etc.9 Dissolution in 
turn depends on the solubility of the drug substance in 
surrounding medium. For drugs absorbed by passive 
diffusion, those exhibiting low aqueous solubility tend to 
have a slower oral absorption rate than those exhibiting high 
aqueous solubility. 10,11,12 
Techniques of solubility improvement13,14,15 
As Solubility and Permeability is the deciding factor for the 
in-vivo absorption of the drug, these can be altered or 
modified by enhancement techniques like, 
A) Physical modifications 
            a) Particle Size Reduction 
1) Micronization 
2) Nanosuspension  
3)Sonocrystallisation 
4) Supercritical fluid process 
5)Spray drying 
b) Modification of the crystal habit  
c) Drug dispersion in carriers  
d) Complexation 
 1) Staching Complexes 
 2) Inclusion Complexes 
e) Solubilization by surfactants 
1) Microemulsions  
2) Self microemulsifying drug delivery systems  
f)Novel drug-drug solid dispersion 
B) Chemical modifications   
              1) Salt Formation  
              2) Co-crystallization  
              3) Co-solvency  
              4) Hydrotropy  
              5) Use of novel solubilizer  
              6) Nanotechnology  
  
A) Physical modifications 
a) Particle Size Reduction: 
Particle size reduction increases the effective surface area 
resulting in enhancement of solubility and dissolution 
velocity of the drug. Nanonization techniques are generally 
employed to improve solubility and dissolution rate of drugs 
in order to improve its oral bioavailability. 15,16 
1) Micronization: 
Micronisation increases the dissolution rate of drugs through 
increased surface area; it does not increase equilibrium 
solubility. Micronization of drugs can be done by milling 
techniques using jet mill, rotor stator colloid mills, etc. 
However, it is not suitable for drugs having a high dose 
number because it does not change the saturation solubility 
of the drug.17 
2) Nanosuspension: 
Another approach used to reduce the particle size is 
nanonization which generally results in formation of 
nanosuspension- a sub-micron colloidal dispersion of pure 
particles of drug stabilized by surfactants. It increases 
dissolution rate due to larger surface area exposed to 
gastrointestinal fluid. The numerous of compound having 
improve the dissolution rate and bioavaibility of various 
drug are badly soluble in water. The another methods are 
used in nanonization like spray drying, pear milling, wet 
milling, homogenization etc.18 
3) Sonocrystallisation: 
Recrystallization of poorly soluble materials using liquid 
solvents and antisolvents has also been employed 
successfully to reduce particle size. Sonocrystallisation 
utilizes ultrasound power characterised by a frequency 
range of 20–100 kHz for inducing crystallisation. It not only 
enhances the nucleation rate but also an effective means of 
size reduction and controlling size distribution of the active 
pharmaceutical ingredients. Most applications use 
ultrasound in the range 20 kHz-5 MHz. 19 
4) Supercritical fluid process: 
Supercritical fluids are fluids whose temperature and 
pressure are greater than its critical temperature (Tc) and 
critical pressure (Tp), allowing it to assume the properties of 
both a liquid and a gas. At near-critical temperatures, SCFs 
are high compressible, allowing moderate changes in 
pressure to greatly alter the density and mass transport 
characteristics of a fluid that largely determine its solvent 
power. Once the drug particles are solubilised within SCF, 
they may be recrystallized at greatly reduced particle 
sizes.20,21 
5) Spray dried solid dispersion technology  
Spray drying technology can be defined as a unit operation in 
which a liquid stream is constantly divided into very fine 
droplet into a glass compartment where they come in 
contact with hot gas and get dried into fine particles, which 
are further separated from the drying gas using a cyclone or 
a bag-filter. Spray driers can operate in open cycle mode for 
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aqueous based or in closed-loop mode for organic based 
system.22,23 
6) Self-nanoemulsifying drug-delivery systems  
Self-nanoemulsifying drug-delivery systems have emerged 
as an effective delivery system due to their proven ability to 
enhance bioavailability of lipophilic drugs. Self nano 
emulsifying drug-delivery systems is a thermodynamically 
stable isotropicmixture of oil, surfactant, co-surfactant and 
drug that form a spontaneous oil-in-water nanoemulsion 
with a droplet size less than 100 nm when introduced into an 
aqueous medium under gentle agitation. Several potential 
advantages of SNEDDS include their ability to present drug 
in a solubilized form inside the gastrointestinal lumen, thus 
providing greater interfacial area for drug absorption, 
providing greater chemical and enzymatic stability, 
inhibiting P-glycoprotein mediated drug efflux, enhancing 
lymphatic transport.24 
7) Pharmaceutical particle technologies 
Pharmaceutical particle technology is employed to improve 
poor aqueous solubility of drug compounds that limits in 
vivo bioavailability owing to their low dissolution rate in the 
gastrointestinal fluids following oral administration.25,26 
8) Milling techniques for improving the solubility 
Milling involves the application of mechanical energy to 
physically break down coarse. A myriad of milling 
techniques and equipment are now available for particle size 
reduction of drugs, with many capable of scaling up and 
adaptable to consistent and continuous manufacturing. The 
mechanisms by which milling enhances drug dissolution and 
solubility include alterations In the size, specific surface area 
and shape of the drug particles as well as milling induced 
amorphization and/or structural disordering of the drug 
crystal.26 
9) Solubility and Dissolution Enhancement by Spherical 
Crystallization 
Spherical crystallization technique combines crystallization 
followed by agglomeration to generate spherical crystals 
with improved micromeretic properties, thus obviating need 
for further processing by agglomeration and granulation.27 
10) Nanostructured lipid carriers for oral bioavailability 
enhancement  
Nano particulate carrier systems. Polymeric and solid lipid 
nanoparticles are two varieties of such Nano carrier systems. 
Polymeric nanoparticles suffered with some drawbacks like 
toxicity and unavailability of some good techniques for 
production of nanoparticles at large scale. 
11) Microwave Irradiation  
This method is developed for rapid organic synthesis and 
reactions, which require shorter reaction time and higher 
aim product. 
12) Modification of the crystal habit 
Polymorphism is the ability of an element or compound to 
crystallize in more than one crystalline form. Polymorphs of 
a drug are chemically identical, but they exhibit different 
physicochemical properties including solubility, melting 
point, density, texture, stability etc. Based on the 
thermodynamic properties, polymorphs can be classified as 
enantiotropes and monotropes. In enantiotropic system, one 
polymorphs form can change reversibly into another at a 
definite transition temperature below the melting point, 
while no reversible transition is possible for monotropes. 28 
13) Drug dispersion in carriers: 
In this technique, a poorly soluble drug is dispersed in a 
highly soluble solid hydrophilic matrix, which enhances the 
dissolution of the drug. Solid dispersion techniques can yield 
eutectic (non-molecular level mixing) or solid solution 
(molecular level mixing) products. Eutectic dispersions are 
homogeneous dispersions of crystalline or amorphous drugs 
in crystalline or amorphous carriers. In the solid solution 
form, the drug could be partially or completely soluble in the 
dispersing matrix.28 
14) Complexation: 
Complexation is the association between two or more 
molecules to form a nonbonded entity with a well defined 
stichiometry. Complexation relies on relatively weak forces 
such as London forces, hydrogen bonding and hydrophobic 
interactions. 
15) Staching Complexation: 
Staching complexes are formed by the overlap of the planar 
regions of aromatic molecules. Nonpolar moieties tend to be 
squeezed out of water by the strong hydrogen bonding 
interactions of water. This causes some molecules to 
minimize the contact with water by aggregation of their 
hydrocarbon moieties. This aggregation is favored by large 
planar nonpolar regions in the molecule. Stached complexes 
can be homogeneous or mixed. The former is known as self 
association and latter as complexation. Some compounds 
that are known to form staching complexes are 
Nicotinamide, Anthracene, Benzoic acid, Salicylic acid, etc. 
16) Inclusion complexation 
Inclusion complexes are formed by the insertion of the 
nonpolar molecule or the nonpolar region of one molecule 
(known as guest) into the cavity of another molecule or 
group of molecules (known as host). Cyclodextrins and their 
derivatives have been employed as host for inclusion 
complex to increase water solubility, dissolution rate and 
bioavailability of lipophilic drugs for oral or parenteral 
delivery. 29 
e) Solubilization by Surfactants: 
Surfactants are molecules with distinct polar and nonpolar 
regions in which hydrocarbon segment is connected to a 
polar group which may be anionic, cationic, zwitterionic or 
nonionic. The presence of surfactants may lower the surface 
tension and increase the solubility of the drug. 
Microemulsions and SEDDS are drug delivery systems based 
on this concept. 29 
17)Microemulsion 
Microemulsions have been employed to increase the 
solubility of many drugs that are practically insoluble in 
water, along with incorporation of proteins for oral, 
parenteral, as well as percutaneous / transdermal use. 
Microemulsions are isotropic, thermodynamically stable 
transparent (or translucent) systems of oil, water and 
surfactant, frequently in combination with a co-surfactant 
with a droplet size usually in the range of 20-200 nm.These 
homogeneous systems, which can be prepared over a wide 
range of surfactant concentration and oil to water ratio, are 
all fluids of low viscosity. 29 
18) Novel drug-drug solid dispersion 
The drug-drug solid dispersion is defined as the it is the 
solubility enhancement method in the category of solid 
dispersion with use of two drug in which insoluble drug are 
dispersed in soluble drug without physiological inert carrier 
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and soluble drug it self act as carrier  for  solubility. By using 
this we can give combination of drug any which contain poor 
& highly soluble drug because fixed dose combination of 
drug become rule for combating  many clinical disorder so it 
is very beneficial and we are convert the fixed dose 
combination having the soluble insoluble combination into 
the solid dispersion form etc. The drug-drug solid dispersion 
are the novel approach to   enhanced the solubility   to 
avoiding the physiological inert carrier.30 
B) Chemical modifications31,32 
1) pH Adjustment: 
For organic solutes that are ionizable, changing the pH of the 
system may be simplest and most effective means of 
increasing aqueous solubility. Under the proper conditions, 
the solubility of an ionizable drug can increase exponentially 
by adjusting the pH of the solution. A drug that can be 
efficiently solubilized by pH control should be either weak 
acid with a low pKa or a weak base with a high 
pKa.Furosemide (pKa of 3.9) is unstable at an acid pH, but is 
very stable under alkaline conditions. In dogs, the oral 
bioavailability is approximately 77%. 
2) Salt formation:  
Salt formation is the most common and effective method of 
increasing solubility and dissolution rates of acidic and basic 
drugs. It can lead to changes in solubility and permeability of 
the parent molecule, which can lead to improved 
bioavailability. The use of salt forms is a well known 
technique to enhance dissolution rates. Generally, an 
alkaloidal base is slightly soluble in water, but if the pH of 
medium is reduced by addition of acid, the solubility of the 
base is increased as the pH continues to be reduced. 
Example: Rosiglitazone maleate, Pioglitazone HCl, Atropine 
sulphate 
3) Co-crystallisation: 
Co crystals are defined as crystalline complexes of two or 
more neutral molecular constituents bound together in the 
crystal lattice through non covalent interactions. 
Cocrystallization is a flourishing research field with direct 
application to the pharmaceutical industry.The new 
approach available for the enhancement of drug solubility is 
through the application of the co-crystals, it is also referred 
as molecular complexes. If the solvent is an integral part of 
the network structure and forms at least two component 
crystal, then it may be termed as co-crystal. If the solvent 
does not participate directly in the network itself, as in open 
framework structures, then it is termed as clathrate 
(inclusion complex). A co-crystal may be defined as a 
crystalline material that consists of two or more molecular 
(and electrically neutral) species held together by non-
covalent forces.23 Different techniques for co crystallization 
1)Solvent evaporation 2)Grinding 3)Slurry Co - 
Crystallization 4)Solvent drop grinding (Modification of 
Grinding) 5)High throughput co-crystallization  6)Hot melt 
extrusion 7) Sonocrystallization Method. Few example of 
research work done cocrystal formation Flurbiprofen, 
Itraconazole ,Carbamazepine etc. 
Co Crystals Characterization Parameters 1) Solubility 2) 
Maximum wavelength 3) Stability 4) Intrinsic dissolution 5) 
Bioavailability 6) Melting Point 7) Melt (Hot stage 
microscopy) 8) DSC 9) XRD 10) Vibrational spectroscopy. 
4) Cosolvency: 
The solubility of a poorly water soluble drug can be 
increased frequently by the addition of a water miscible 
solvent in which the drug has good solubility known as 
cosolvents. Co-solvents are mixtures of water and one or 
more water miscible solvents used to create a solution with 
enhanced solubility for poorly soluble compounds. Co-
solvent formulations of poorly soluble drugs can be 
administered orally and parenterals. The pharmaceutical 
form is always liquid. Poorly soluble compounds which are 
lipophilic or highly crystalline that have a high solubility in 
the solvent mixture may be suited to a co-solvent approach. 
Commonmly used cosolvents Glycerol, propylene glycol, PEG 
400, Dimethyl Sulfoxide, Dimethyl Acetamide, Ethanol, n-
Octanol are the commonly used cosolvents.  
Ideal behaviour of Cosolvents  
 It should be easily available and sufficiently pure. 
 It should be non-toxic, non-irritating, and 
nonsensitizing. 
  It also must exert no pharmacologic activity of its own. 
 It should be stable under normal conditions of 
pharmaceutical use. 
 It should not adversely affect the action of the 
medicament. 
 Ideal solvent should not be affected by acids or alkalies. 
 The viscosity of solvent should be as such so as to allow 
ease of administration. 
 It should remain fluid over a wide temperature range31. 
5) Hydrotropy: 
Hydrotropy is a solubilization phenomenon whereby 
addition of large amount of a second solute results in an 
increase in the aqueous solubility of another solute. 
Concentrated aqueous hydrotropic solutions of sodium 
benzoate, sodium salicylate, urea, nicotinamide, sodium 
citrate and sodium acetate have been observed to enhance 
the aqueous solubilities of many poorly water-soluble drugs. 
Significance of Hydrotrophy  
 Hydrotropy is suggested to be superior to other 
solubilization method, such as miscibility, micellar 
solubilization, co solvency and salting in, because the 
solvent character is independent of pH, has high 
selectivity and does not require emulsification.  
 It only requires mixing the drug with the hydrotrope in 
water and do not require chemical modification of 
hydrophobic drugs, use of organic solvents, or 
preparation of emulsion system.  
 Solvent character is independent of pH, hydrotrophy 
has high selectivity and does not require emulsification.  
6) Use of novel solubilizer:  
The solubility of poorly soluble drug can also be improved by 
various solubilizing materials. Ex. Conventional solubilizer 
Polysorbates, PEG 400 Sepitrap,Soluplus  Povacoat, 
dendrimers, is improve the solubility of hydrophobic API. 
7) Nanotechnology approaches: 
Nanotechnology can be used to improve solubility. 
Nanotechnology refers broadly to the study and use of 
materials and structures at the nanoscale level of 
approximately 100 nanometers (nm) or less. For many new 
chemical entities of very low solubility, oral bioavailability 
enhancement by micronisation is not sufficient because 
micronized product has the tendency of agglomeration, 
which leads to decreased effective surface area for 
dissolution and the next step taken was Nanonisation.32 
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Conclusion 
From the above article we conclude that the solubility of the 
drug is the most critical factor in the formulation 
development that controls the therapeutic efficacy of the 
drug. The various techniques described above can be used to 
enhance the solubility of the drug. The choice of the method 
will be based on its effectiveness as well as safety in terms of 
biocompatibility of the excipient used. A lot of research has 
been carried out in this area and some improvements in 
solubility and dissolution rate has to be made generally. 
Researcher working on solubility enhancement may use 
following techniques Chemical modification methods like 
Salt formation, Co-crystallization, Co-solvency, Hydrotropy, 
use of novel solubilize etc along with physical modification 
techniques & try to remove drawbacks of individual 
technique. 
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